| General Information of This Metabolic Reaction (MR) (ID:
MR000945) |
| Formula |
Reactant |
Eslicarbazepine |
Product |
Eslicarbazepine-O-glucuronide metabolite |
|
Reactant Info
|
Product Info
|
|
Metabolic Enzyme
|
UDP-glucuronosyltransferase 1A1 (UGT1A1)
|
DME Info
|
|
|
|
|
|
|
|
| Other MR(s) Related to The Reactant of This MR |
|
Other MR(s) That Produce The Reactant of This MR
|
|
|
|
Other MR(s) That Metabolize The Reactant of This MR
|
|
|
| References |
| 1 |
Pharmacokinetics and drug interactions of eslicarbazepine acetate Epilepsia. 2012 Jun;53(6):935-46. doi: 10.1111/j.1528-1167.2012.03519.x.
|
| 2 |
The role of carbonyl reducing enzymes in oxcarbazepine in vitro metabolism in man. Chem Biol Interact. 2014 Sep 5;220:241-7.
|
| 3 |
U. S. FDA Label -Eslicarbazepine acetate
|
| 4 |
Key factors in the discovery and development of new antiepileptic drugs Nat Rev Drug Discov. 2010 Jan;9(1):68-82. doi: 10.1038/nrd2997.
|
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.